Tokyo Institute of Technology merged with Tokyo Medical and Dental University to form Institute of Science Tokyo (Science Tokyo) on October 1, 2024.
Over time, content on this site will be migrated to the Science Tokyo Web
. Any information published on this site will be valid in relation to Science Tokyo.
Tokyo Tech News
Published: April 7, 2020
Expectations are growing for Boron Neutron Capture Therapy (BNCT), a new cancer treatment, with few side effects, that combines thermal neutron irradiation and drug delivery. In BNCT, drugs are used to introduce boron specifically into cancer cells. The cancer cells are then irradiated, killing them with thermal neutrons. By targeting cancer at the cellular level, the treatment limits effects on healthy tissue.
Professor Nobuhiro Nishiyama and Assistant Professor Takahiro Nomoto used slime chemistry to develop a new drug complex that enhances the therapeutic effect of BNCT. They presented their findings at a press briefing held on January 22 at Tokyo Tech. This 4-minute video provides an overview of their achievement.
Further Information
Office of Research and Innovation
Email ru.staff@jim.titech.ac.jp
Tel +81-3-5734-3188
Contact
Public Relations Section, Tokyo Institute of Technology
Email media@jim.titech.ac.jp
Tel +81-3-5734-2975
© Institute of Science Tokyo. All rights reserved.
